TITLE

A MILESTONE IN THROMBOEMBOLIC DISEASE

AUTHOR(S)
Halpern, Alfred; Samuels, Saul S.
PUB. DATE
August 1959
SOURCE
Angiology;Aug1959 Part 2, Vol. 10 Issue 4, p243
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Looks into developments in the study of thromboembolic disease. Therapeutic potential of a fibrinolytic enzyme; Investigation of a particular type of fibrnolysin in many human thromboembolic states; Discussion by a group of investigators of their experiences with fibrinolysin.
ACCESSION #
16388343

 

Related Articles

  • EARLY EXPERIENCE WITH FIBRINOLYSIN. Cliffton, Eugene E. // Angiology;Aug1959 Part 2, Vol. 10 Issue 4, p244 

    In this paper attempts have been made to bring together the apparently divergent opinions of several groups of investigators. The differences seem to be largely matters of semantics and variations in methods and techniques of measurement of activity and in material available for testing rather...

  • FIBRINOLYSIN THERAPY OF THROMBOEMBOLISM: THREE YEARS' EXPERIENCE. Sheffer, Albert L.; Lisker, Samuel; Nemir Jr., Paul // Angiology;May1961, Vol. 12 Issue 5, p165 

    The clinical evaluation of 67 patients treated with fibrinolysin is presented. Thirty-three cases reported previously are added for follow-up purposes. Thrombophlebitis, pulmonary embolism, vascular surgery and ophthalmologic experience are described. There are a few encouraging examples in each...

  • THROMBOLYTIC THERAPY. Loewe, Leo; Halpern, Alfred // Angiology;May1961, Vol. 12 Issue 5, p147 

    Discusses the fibrinolytic treatment of thromboembolic disease. Potential of fibrinolysin, a fibrinolytic agent to dissolve thrombi within the circulation; Capacity to dissolve the fibrin binding the clot without affecting the other proteins in the blood producing adverse reactions; Influence of...

  • Plasminogen-related.  // Encyclopedic Reference of Cancer;2001, p701 

    A definition of the term "plasminogen-related protein" is presented. It refers to a protein that shares structural similarity and evolutionary relationship with plasminogen.

  • Urokinase stimulates inflammatory response in damaged vascular wall during in vivo arterial remodeling. O. Plekhanova; M. Menshikov; M. Solomatina; E. Ratner; V. Tkachuk; Ye. Parfyonova // Bulletin of Experimental Biology & Medicine;Jan2008, Vol. 145 Issue 1, p10 

    Abstract  Perivascular application of urokinase to the ballooned artery promoted the growth of neointima and constrictive remodeling of the vessel and stimulated the inflammatory response in the damaged vascular wall in vivo. Recombinant tissue plasminogen activator did not induce these...

  • Acute Stroke with Hyperdense Middle Cerebral Artery Sign Benefits from IV rtPA. Tartaglia, M. C.; Di Legge, S.; Saposnik, G.; Jain, V.; Chan, R.; Bussière, M.; Hachinski, V.; Frank, C.; Hesser, K.; Pelz, D. // Canadian Journal of Neurological Sciences;Nov2008, Vol. 35 Issue 5, p583 

    Objectives: The current management of acute ischemic stroke is intravenous (IV) recombinant tissue plasminogen activator (rtPA). The presence of a hyperdense middle cerebral artery sign (HMCAS) on pre-treatment head computed tomogram (CT) is considered a poor prognostic sign. We compared the...

  • Plasminogen Activator Inhibitor-1 4G/5G Gene Polymorphism and Coronary Artery Disease in the Chinese Han Population: A Meta-Analysis. Yan-yan Li // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background: The polymorphism of plasminogen activator inhibitor-1 (PAI-1) 4G/5G gene has been indicated to be correlated with coronary artery disease (CAD) susceptibility, but study results are still debatable. Objective and Methods: The present meta-analysis was performed to investigate the...

  • Plasminogen Activator Inhibitor-1 4G/5G Gene Polymorphism and Coronary Artery Disease in the Chinese Han Population: A Meta-Analysis. Yan-yan Li // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background: The polymorphism of plasminogen activator inhibitor-1 (PAI-1) 4G/5G gene has been indicated to be correlated with coronary artery disease (CAD) susceptibility, but study results are still debatable. Objective and Methods: The present meta-analysis was performed to investigate the...

  • THE USE OF FIBRINOLYSIN IN THE PREVENTION OF THROMBUS FORMATION IN SMALL ARTERY ANASTOMOSES. Engler, Harold S.; Christopher, Phillip; Moretz, William H. // Angiology;Aug1959 Part 2, Vol. 10 Issue 4, p259 

    A study of the use of fibrinolysin in the prevention of thrombus formation in small artery anastomoses is reported. Under the conditions of this experiment no beneficial effect was observed. Our experience with the use of fibrinolysin in 9 vascular operations is also described briefly. With the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics